Nanotechnology in Neuroscience and Neuroengineering

Neuroengineering focuses on the development of artificial devices and novel materials to be functionally and structurally interfaced with the central nervous system (CNS). Today, there is the expectation that materials science and nanotechnology will be able to address these challenges and lead to breakthroughs at the level of the interfaces between artificial transducers/actuators and living cells. Nanoparticles are able to penetrate the BBB of in vitro and in vivo models; and therefore can be used to develop diagnostic tools as well as nano-enabled delivery systems that can bypass the BBB in order to facilitate conventional and novel neurotherapeutic interventions such as drug therapy, gene therapy, and tissue regeneration.

 

  • Up-take mechanisms of nanoparticles into brain
  • Advances in the treatment of Alzheimer’s disease with nanoparticle
  • Advances in the treatment of Parkinson’s disease with nanoparticle
  • Advances in the treatment of huntington disease with nanoparticle
  • Advances in the treatment of vascular dementia disease with nanoparticle
  • Advances in the treatment of lewd body dementia disease with nanoparticle
  • Advances in the treatment of frontotemporal disease with nanoparticle
  • Current and future development

Related Conference of Nanotechnology in Neuroscience and Neuroengineering

October 21-22, 2025

42nd Global Summit on Nanoscience and Technology

London, UK
December 22-23, 2025

42nd Global Nanotechnology Congress

Amsterdam, Netherlands
February 09-10, 2026

9th International Conference on Nanomedicine and Nanotechnology

Singapore City, Singapore
March 23-24, 2026

29th World Nanotechnology Congress

Paris, France

Nanotechnology in Neuroscience and Neuroengineering Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in